China Pharma Holdings, Inc.
CPHI
$1.75
-$0.035-1.97%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -785.60K | -1.22M | -1.12M | -1.44M | -955.90K |
| Total Depreciation and Amortization | 329.30K | 448.10K | 696.90K | 739.30K | 733.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 212.10K | -12.30K | 50.90K | 419.90K | 124.20K |
| Change in Net Operating Assets | 186.40K | 1.03M | 323.10K | 206.20K | -487.30K |
| Cash from Operations | -57.80K | 238.50K | -47.00K | -72.70K | -585.20K |
| Capital Expenditure | -58.30K | -19.50K | 9.20K | -28.10K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -22.60K | -253.30K | -- | -- | -- |
| Cash from Investing | -81.00K | -272.90K | 9.20K | -28.10K | -- |
| Total Debt Issued | -- | 6.80K | 6.80K | 499.60K | -- |
| Total Debt Repaid | -76.80K | 0.00 | 0.00 | -492.80K | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 6.80K | -- | -- | -- | 6.90K |
| Cash from Financing | -70.00K | 6.80K | 6.80K | 6.90K | 6.90K |
| Foreign Exchange rate Adjustments | -5.40K | -64.20K | 10.20K | -5.60K | -6.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -214.20K | -91.80K | -20.60K | -99.50K | -585.00K |